Profile data is unavailable for this security.
About the company
Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
- Revenue in SEK (TTM)102.18m
- Net income in SEK-2.52m
- Incorporated1990
- Employees36.00
- LocationIntegrum ABGemenskapens gata 9MOELNDAL 431 53SwedenSWE
- Phone+46 317601060
- Fax+46 31155260
- Websitehttps://integrum.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acarix AB | 6.26m | -70.95m | 302.73m | 9.00 | -- | 4.41 | -- | 48.38 | -0.1168 | -0.1168 | 0.0095 | 0.0697 | 0.0894 | 0.1172 | 2.47 | -- | -101.38 | -66.93 | -123.43 | -77.12 | 88.27 | 79.42 | -1,133.87 | -1,483.68 | 5.21 | -328.98 | 0.00 | -- | 7.20 | 43.55 | -1.11 | -- | -- | -- |
| INIFY Laboratories AB | 3.42m | -51.43m | 322.69m | 23.00 | -- | 4.67 | -- | 94.30 | -1.18 | -1.18 | 0.0787 | 1.68 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Karolinska Development AB | 1.90m | -5.65m | 325.45m | 8.00 | -- | 0.2565 | -- | 171.02 | -0.0209 | -0.0209 | 0.007 | 4.56 | 0.0015 | -- | 1.38 | 237,875.00 | -0.4536 | 3.37 | -0.4578 | 3.83 | -- | -- | -296.85 | 1,466.36 | -- | -- | 0.0021 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
| Boule Diagnostics AB | 572.53m | 21.28m | 341.62m | 230.00 | 16.36 | 0.6871 | 7.20 | 0.5967 | 0.5368 | 0.5368 | 14.45 | 12.78 | 0.724 | 4.19 | 3.69 | 2,511,092.00 | 2.68 | 1.67 | 3.71 | 2.40 | 43.86 | 43.50 | 3.70 | 2.04 | 0.9268 | 4.72 | 0.2698 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Q linea AB | 4.70m | -224.61m | 385.95m | 99.00 | -- | 5.02 | -- | 82.20 | -2.06 | -2.06 | 0.0428 | 0.5813 | 0.0277 | 0.1707 | 11.86 | 36,968.50 | -132.70 | -59.66 | -356.93 | -66.14 | -56.25 | -378.58 | -4,783.96 | -4,046.97 | 0.6999 | -- | 0.4555 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
| ContextVision AB | 132.39m | 25.69m | 415.02m | 41.00 | 14.76 | 4.22 | 12.05 | 3.13 | 0.3456 | 0.3456 | 1.78 | 1.21 | 1.21 | 2.33 | 4.81 | 3,444,860.00 | 23.39 | 29.39 | 30.67 | 43.27 | 97.39 | 98.58 | 19.40 | 27.15 | 3.99 | -- | 0.0304 | -- | 12.19 | 7.78 | -1.77 | -- | -35.88 | -- |
| BrainCool AB (publ) | 32.23m | -57.17m | 489.00m | 20.00 | -- | 2.98 | -- | 15.17 | -0.2685 | -0.2685 | 0.1501 | 0.6527 | 0.2253 | 2.04 | 2.85 | 1,343,042.00 | -39.96 | -47.14 | -44.79 | -70.16 | -37.24 | -149.77 | -177.38 | -391.45 | 4.16 | -6.19 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| SyntheticMR AB (publ) | 81.53m | 4.72m | 491.46m | 43.00 | 115.52 | 4.82 | 43.31 | 6.03 | 0.1134 | 0.1134 | 1.96 | 2.72 | 0.6049 | -- | 1.53 | 2,203,514.00 | 3.50 | 7.19 | 4.24 | 8.85 | 70.27 | 69.70 | 5.79 | 9.08 | -- | 18.00 | 0.0066 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
| Integrum AB | 102.18m | -2.52m | 533.30m | 36.00 | -- | 2.80 | 703.63 | 5.22 | -0.1244 | -0.1244 | 5.29 | 9.58 | 0.5706 | 0.5666 | 3.59 | 2,620,068.00 | -1.41 | -1.71 | -1.55 | -1.98 | 87.25 | 83.87 | -2.47 | -2.87 | 5.54 | -0.6636 | 0.0325 | -- | 40.19 | 35.91 | 124.92 | -- | 127.10 | -- |
| Modulight Oyj | 38.85m | -133.48m | 547.08m | 79.00 | -- | 0.9021 | -- | 14.08 | -0.2844 | -0.2844 | 0.0836 | 1.22 | 0.0516 | -0.3111 | 1.94 | 49,271.43 | -17.72 | -8.39 | -18.97 | -9.10 | 123.49 | 114.69 | -343.58 | -56.81 | 4.50 | -- | 0.0965 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| Bioretec Oy | 45.91m | -39.76m | 599.32m | 43.00 | -- | 8.65 | -- | 13.05 | -0.1752 | -0.1752 | 0.2024 | 0.318 | 0.4104 | 1.23 | 3.75 | 110,166.80 | -35.54 | -66.83 | -40.92 | -97.19 | 69.97 | 70.97 | -86.61 | -133.49 | 4.04 | -- | 0.0696 | -- | 32.78 | 19.77 | -54.02 | -- | -- | -- |
| Gentian Diagnostics ASA | 140.56m | -1.93m | 674.68m | 58.00 | -- | 4.21 | 96.81 | 4.80 | -0.1369 | -0.1369 | 9.43 | 10.20 | 0.7756 | 1.71 | 6.79 | 2,522,379.00 | -1.07 | -10.76 | -1.21 | -11.86 | 51.06 | 41.46 | -1.37 | -26.99 | 4.83 | -- | 0.047 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| OssDsign AB | 123.46m | -113.80m | 679.17m | 27.00 | -- | 2.91 | -- | 5.50 | -1.40 | -1.40 | 1.43 | 2.30 | 0.4311 | 2.50 | 6.80 | 2,572,083.00 | -39.74 | -37.92 | -43.39 | -43.56 | 83.94 | 68.10 | -92.18 | -203.06 | 5.92 | -21.65 | 0.0114 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Mentice AB | 280.75m | -10.20m | 696.59m | 134.00 | -- | 4.64 | 42.12 | 2.48 | -0.3998 | -0.3998 | 10.95 | 5.97 | 0.9046 | 3.05 | 3.28 | 2,301,221.00 | -3.29 | -7.69 | -6.32 | -13.07 | 85.36 | 83.67 | -3.63 | -10.00 | 1.00 | -- | 0.0382 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Omda AS | 400.97m | 86.96m | 727.65m | 295.00 | 6.95 | 10.84 | 4.96 | 1.81 | 4.35 | 4.35 | 20.60 | 2.79 | 0.5886 | 238.36 | 10.38 | 1,434,162.00 | 13.80 | -4.92 | 18.03 | -6.37 | 92.89 | 90.22 | 23.45 | -9.83 | 1.14 | 2.56 | 0.8946 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
Data as of Sep 27 2024. Currency figures normalised to Integrum AB's reporting currency: Swedish Krona SEK
17.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fiducian Investment Management Services Ltd.as of 30 Dec 2022 | 732.77k | 4.12% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 2023 | 717.49k | 4.03% |
| Stena Finance ABas of 30 Dec 2022 | 450.00k | 2.53% |
| Swedbank Robur Fonder ABas of 28 Jun 2024 | 450.00k | 2.53% |
| Didner & Gerge Fonder ABas of 30 Dec 2022 | 400.00k | 2.25% |
| Mandarine Gestion SAas of 29 Feb 2024 | 237.50k | 1.34% |
| East Capital Financial Services ABas of 31 Jul 2024 | 90.00k | 0.51% |
| E. �hman J :or Fonder ABas of 31 May 2024 | 23.76k | 0.13% |
| AXA Investment Managers (Paris) SAas of 31 Oct 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2022 - 31 Jul 2024Source: FactSet Research Systems Inc.
